CoChat

Safety and Liver Transduction Efficacy of rAAV5- cohPBGD in Nonhuman Primates: A Potential Therapy for Acute Intermittent Porphyria

Open access
Pañeda, Astrid, Lopez-Franco, Esperanza, Kaeppel, Christine, Unzu, Carmen, Gil-Royo, Ana Gloria, D'Avola, Delia, Beattie, Stuart G., Olagüe, Cristina, Ferrero, Roberto, Sampedro, Ana, Mauleon, Itsaso, Hermening, Stephan, Salmon, Florence, Benito, Alberto, Gavira, Juan Jose, Cornet, María Eugenia, del Mar Municio, María, von Kalle, Christof, Petry, Harald, Prieto, Jesus, Schmidt, Manfred, Fontanellas, Antonio, González-Aseguinolaza, Gloria · 2013 · Human Gene Therapy
Cited by 60

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Abstract

Acute intermittent porphyria (AIP) results from haplo-insufficient activity of porphobilinogen deaminase (PBGD) and is characterized clinically by life-threatening, acute neurovisceral attacks. To date, liver transplantation is the only curative option for AIP. The aim of the present preclinical nonhuman primate study was to determine the safety and transduction efficacy of an adeno-associated viral vector encoding PBGD (recombinant AAV serotype 5-codon-optimized human porphobilinogen deaminase, rAAV5-cohPBGD) administered intravenously as part of a safety program to start a clinical study in patients with AIP. Macaques injected with either 1 × 10(13) or 5 × 10(13) vector genomes/kg of clinical-grade rAAV5-cohPBGD were monitored by standardized clinical parameters, and vector shedding was analyzed. Liver transduction efficacy, biodistribution, vector integration, and histopathology at day 30 postvector administration were determined. There was no evidence of acute toxicity, and no adverse effects were observed. The vector achieved efficient and homogenous hepatocellular transduction, reaching transgenic PBGD expression levels equivalent to 50% of the naturally expressed PBGD mRNA. No cellular immune response was detected against the human PBGD or AAV capsid proteins. Integration site analysis in transduced liver cells revealed an almost random integration pattern supporting the good safety profile of rAAV5-cohPBGD. Together, data obtained in nonhuman primates indicate that rAAV5-cohPBGD represents a safe therapy to correct the metabolic defect present in AIP patients.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1089/hum.2013.166

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Cited by

Metadata

Authors
Pañeda, A., Lopez-Franco, E., Kaeppel, C., Unzu, C., Gil-Royo, A. G., D'Avola, D., Beattie, S. G., Olagüe, C., Ferrero, R., Sampedro, A., Mauleon, I., Hermening, S., Salmon, F., Benito, A., Gavira, J. J., Cornet, M. E., del Mar Municio, M., von Kalle, C., Petry, H., Prieto, J., Schmidt, M., Fontanellas, A., & González-Aseguinolaza, G.
Venue
Human Gene Therapy
Published
2013-12
Volume
24
Issue
12
Pages
1007-1017
ISSN
  • 1043-0342 (ISSN-L)
  • 1557-7422
OpenAlex
W1933310330
Cited by
60
References
8
FWCI
5.46
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.